Skip to main navigation

menu

Aclaris - Corp Menu

About Us »
« Back
Research »
« Back
Products
Citizenship »
« Back
Careers
Insights
Investors »
« Back

Aclaris - Extras Menu

Media resources
Contact us

Aclaris - Corp Menu

About Us »
« Back
Research »
« Back
Products
Citizenship »
« Back
Careers
Insights
Investors »
« Back

Aclaris - Investor Relations

Investor overview
Stock information
Press releases
Events
SEC filings
Corporate governance
Investor presentations
Investor FAQs
Email alerts

Investor contact

For investor related questions, please email

investors@aclaristx.com

Media contact
& resources »

Investor Overview

Stock quote

VOLUME:

View stock performance »

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Overview

Press Releases

May 26, 2020

Aclaris Therapeutics to Present at the Jefferies Virtual Healthcare Conference

May 7, 2020

Aclaris Therapeutics Reports First Quarter 2020 Financial Results and Provides R&D and Business Highlights

March 31, 2020

Aclaris Therapeutics Secures $11 Million Term Loan Facility

Events

Jun 3, 2020
1:00 PM EDT

Aclaris Therapeutics, Inc. at Jefferies Virtual Healthcare Conference

Feb 25, 2020
5:00 PM EST

Q4 2019 Aclaris Therapeutics Inc. Earnings Conference Call

Nov 7, 2019
5:00 PM EST

Q3 2019 Aclaris Therapeutics Inc. Earnings Conference Call

Feature presentation

More presentations coming soon.

Aclaris - Footer Menu

Terms of use
Privacy policy
Media resources
Contact us

© 2020 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.